The use of chemotherapy in patients with gliomas: Patterns of care in Victoria from 1998-2000

Journal of Clinical Neuroscience

Volumn 15, Issue 4, 2008, Pages 398-401

  Cher, Lawrence ^a   Rosenthal, Mark A ^b   Drummond, Katharine J ^b   Dally, Michael ^c   Murphy, Michael ^d   Ashley, David ^e   Thursfield, Vicky ^f   Giles, Graham G ^f  

^a AUSTIN HEALTH   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c ALFRED HOSPITAL   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

^f CANCER EPIDEMIOLOGY CENTRE   (Australia)

Author keywords

Chemotherapy; Glioma

Indexed keywords

CARMUSTINE; LOMUSTINE; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; STATISTICAL SIGNIFICANCE;

ADULT; AUSTRALIA; DRUG THERAPY; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 39649104545     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2007.04.001     Document Type: Article

References (14)

1. De Angelis L.M. Brain tumors. N Engl J Med 344 (2001) 114-123
2. Stupp R., Mason W.P., van den Bent M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 (2005) 987-996
3. Harris M., Rosenthal M.A., Ashley D., et al. An Australian experience with temozolomide for the treatment of recurrent high-grade glioma. J Clin Neurosci 8 (2001) 325-327
4. Yung W.K., Albright R.E., Olson J., et al. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 83 (2000) 588-593
5. Yung WK, Prados MD, Yaya-Tur R, et al. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol 1999;17:2762-71.
6. Stewart L.A. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359 (2002) 1011-1018
7. Rosenthal M.A., Drummond K.J., Dally M., et al. Management of glioma in Victoria (1998-2000): retrospective cohort study. Med J Aust 184 (2006) 270-273
8. Rosenthal M.A., Ashley D.L., and Cher L. BCNU as second line therapy for recurrent high-grade glioma previously treated with Temozolomide. J of Clin Neurosci 11 (2004) 374-375
9. Glantz M., Chamberlain M., Liu Q., et al. Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas. Cancer 97 (2003) 2262-2266
10. Cairncross J.G. Aggressive oligodendroglioma: a chemosensitive tumor. Recent results. Cancer Res 135 (1994) 127-133
11. Kim L., Hochberg F.H., Thornton A.F., et al. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas. J Neurosurg 85 (1996) 602-607
12. Jenkins R.B., Blair H., Ballman K.V., et al. A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res 66 (2006) 9852-9861
13. Chang S.M., Parney I.F., Huang W., et al. Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293 (2005) 557-564
14. Grossman S.A. Arguments against the routine use of currently available adjuvant chemotherapy in high-grade gliomas. Sem Oncol 30 (2003) 19-22